NasdaqCM - Delayed Quote USD

Addex Therapeutics Ltd (ADXN)

Compare
10.30 -0.39 (-3.65%)
At close: October 21 at 4:00 PM EDT
Currency in CHF All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
829.94
1,612.95
1,422.44
2,916.31
3,612.82
--
Cost of Revenue
--
--
--
--
--
230.10
Gross Profit
--
--
--
--
--
2,532.73
Operating Expense
12,034.93
11,894.37
21,942.17
18,422.22
15,856.09
--
Operating Income
-11,204.99
-10,281.42
-20,519.73
-15,505.91
-12,243.27
--
Net Non Operating Interest Income Expense
14.06
42.36
-19.65
-57.69
-34.20
--
Other Income Expense
-665.95
-317.29
-264.36
211.69
-581.13
--
Pretax Income
-11,856.76
-10,556.23
-20,804.21
-15,351.91
-12,858.60
--
Net Income Common Stockholders
4,317.59
-10,556.23
-20,804.21
-15,351.91
-12,858.60
--
Diluted NI Available to Com Stockholders
4,317.59
-10,556.23
-20,804.21
-15,351.91
-12,858.60
--
Basic EPS
4.80
-16.80
-55.20
-54.00
-57.60
--
Diluted EPS
0.00
-16.80
-55.20
-54.00
-57.60
--
Basic Average Shares
749.18
619.23
376.54
284.33
222.35
--
Diluted Average Shares
787.66
619.23
376.54
284.33
222.35
--
Total Operating Income as Reported
-11,204.87
-10,281.30
-20,520.21
-15,505.92
-12,243.27
--
Rent Expense Supplemental
--
35.57
47.28
37.51
12.00
--
Total Expenses
12,034.93
11,894.37
21,942.17
18,422.22
15,856.09
--
Net Income from Continuing & Discontinued Operation
4,317.59
-10,556.23
-20,804.21
-15,351.91
-12,858.60
--
Normalized Income
-11,721.56
-10,238.94
-20,539.85
-15,563.61
-12,277.47
--
Interest Income
35.87
63.96
29.25
5.32
35.31
--
Interest Expense
21.81
21.61
48.90
63.01
69.50
--
Net Interest Income
14.06
42.36
-19.65
-57.69
-34.20
--
EBIT
-11,834.95
-10,534.62
-20,755.32
-15,288.90
-12,789.10
--
EBITDA
-11,419.56
-10,228.67
-20,432.17
-14,941.29
-12,410.34
--
Reconciled Cost of Revenue
--
--
--
--
--
230.10
Reconciled Depreciation
337.51
305.95
323.14
347.61
378.75
--
Net Income from Continuing Operation Net Minority Interest
-11,856.76
-10,556.23
-20,804.21
-15,351.91
-12,858.60
--
Total Unusual Items Excluding Goodwill
-135.20
-317.29
-264.36
211.69
-581.13
--
Total Unusual Items
-135.20
-317.29
-264.36
211.69
-581.13
--
Normalized EBITDA
-11,284.36
-9,911.38
-20,167.81
-15,152.98
-11,829.22
--
12/31/2019 - 2/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers